BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 8221956)

  • 1. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
    Ni SS; Gao ZL
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):81-2, 123. PubMed ID: 8221956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of soluble interleukin 2 receptor in differentiating tuberculous and carcinomatous pleural effusions.
    Chang SC; Hsu YT; Chen YC; Lin CY
    Arch Intern Med; 1994 May; 154(10):1097-101. PubMed ID: 8185423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleural fluid and serum soluble interleukin-2 receptors in pleural effusions.
    Sarandakou A; Poulakis N; Rizos D; Phocas I
    Anticancer Res; 1991; 11(3):1365-8. PubMed ID: 1888173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of tuberculous pleuritis by the measurement of soluble interleukin 2 receptor in pleural fluid.
    Porcel JM; Gázquez I; Vives M; Pérez B; Rubio M; Rivas MC
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):975-9. PubMed ID: 11055766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
    Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
    Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of soluble interleukin-2 receptors in tuberculous pleural effusions.
    Ito M; Kojiro N; Shirasaka T; Moriwaki Y; Tachibana I; Kokubu T
    Chest; 1990 May; 97(5):1141-3. PubMed ID: 2331910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic significance of gamma-interferon in tuberculous pleurisy.
    Poyraz B; Kaya A; Ciledağ A; Oktem A; Gönüllü U
    Tuberk Toraks; 2004; 52(3):211-7. PubMed ID: 15351932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated soluble CD26 levels in patients with tuberculous pleurisy.
    Oshikawa K; Sugiyama Y
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):868-72. PubMed ID: 11573900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating tuberculous from malignant pleural effusions: a scoring model.
    Porcel JM; Vives M
    Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus.
    Pettersson T; Söderblom T; Nyberg P; Riska H; Linko L; Klockars M
    J Rheumatol; 1994 Oct; 21(10):1820-4. PubMed ID: 7837144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleural effusion and serum soluble fas-ligand levels are elevated in different clinical conditions.
    Wang PS; Chen YM; Hsieh YL; Yu CF; Tsai CM; Perng RP
    Lung; 2002; 180(1):25-32. PubMed ID: 12105754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of vascular endothelial growth factor (VEGF) in neoplastic and tuberculosis effusions--preliminary results].
    Jankowska R; Porebska I; Dyła T
    Pneumonol Alergol Pol; 2002; 70(5-6):258-64. PubMed ID: 12518624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elevated soluble interleukin-2 receptor and interleukin-2 receptor positive cells in carcinomatous pleural effusions].
    Kojiro N; Moriwaki Y; Ito M; Nishiki M; Shirasaka T; Kokubu T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):100-4. PubMed ID: 2355670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS; Kostikas K; Oikonomidi S; Tsilioni I; Nikoulis D; Germenis A; Gourgoulianis KI
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble interleukin-6 receptor levels in pleural effusions.
    Yokoyama A; Kohno N; Fujino S; Abe M; Ishida O; Hiwada K
    Respir Med; 1996 Jul; 90(6):329-32. PubMed ID: 8759474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
    Zhou J; Zhao Q; Yao H
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):158-60. PubMed ID: 11778489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of detecting E-selectin of serum and pleural effusion in differentiating benign and malignant diseases].
    Liu G; Li C; Zhong X
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):556-8. PubMed ID: 11360510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
    Moschos C; Porfiridis I; Psallidas I; Kollintza A; Stathopoulos GT; Papiris SA; Roussos C; Kalomenidis I
    Respirology; 2009 Jul; 14(5):716-22. PubMed ID: 19476604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion.
    Kim YK; Lee SY; Kwon SS; Kim KH; Moon HS; Song JS; Park SH
    Lung; 2001; 179(3):175-84. PubMed ID: 11891607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evaluation of soluble IL-2 receptor and type III procollagen N-terminal aminopeptide in pleural fluid for differentiating tuberculous, carcinomatous and parapneumonic pleural effusions.
    Harita S; Nogami N; Kikuchi T; Kibata M
    Respirology; 2002 Dec; 7(4):311-5. PubMed ID: 12421238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.